Posted 3/22/2024, 3:37:28 PM
Medicare to Cover Obesity Drug Wegovy for Those at Risk of Heart Disease
- Medicare Part D plans can now cover Wegovy for patients at risk of heart disease and stroke
- Wegovy is a semaglutide medication that reduces appetite and promotes weight loss
- In trials, Wegovy reduced cardiovascular events by 20% in overweight/obese people
- Coverage does not apply to patients only seeking to lose weight without heart disease
- The move could set a precedent for expanded coverage of anti-obesity drugs
